Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference141 articles.
1. Alvan G, Grind M, Graffner C, Sjöqvist F. Relationship of N-de-methylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism. Clinical Pharmacology and Therapeutics 36: 515–519, 1984
2. Angelo M, Dring LG, Lancaster R, Latham A, Smith RL. A correlation between the response to debrisoquine and the amount of unchanged drug excreted in urine. British Journal of Pharmacology 55: 264p, 1975
3. Angelo M, Dring LG, Lancaster R, Smith RL. The metabolism of debrisoquine in rat and man. Biochemical Society Transactions 4: 704, 1976
4. Arias TD, Jorge LF, Lee D, Barrantes R, Inaba T. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolisers. Clinical Pharmacology and Therapeutics 43: 456–465, 1988
5. Back DJ, Maggs JL, Purba HS. 2-Hydroxylation of ethinylestradiol in relation to the oxidation of sparteine and antipyrine. British Journal of Clinical Pharmacology 18: 603–607, 1984
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献